Sep 6, 2025, 12:52
Which Antiarrhythmics Increase Bleeding Risk with Xa Inhibitors?
Thrombosis & Haemostasis Journal (TH Open) shared a post on X:
“What is the risk of Major Bleeding During Concomitant Use of Antiarrhythmics and Oral Factor Xa Inhibitors? Choi et al. found that Amiodarone, Diltiazem and Verapamil were associated with high bleeding risk, while Dronedarone was not.”
Read more here.
Find similar posts on Hemostasis Today.
-
Mar 11, 2026, 15:46Bleeding and Thrombosis Outcomes in Older Patients With Myelodysplastic Syndromes – JTH
-
Mar 11, 2026, 15:37Sonia Muliyil: The Greatest Benefit is The Wellbeing and Sustenance of Half The World’s Population
-
Mar 11, 2026, 15:34Kymentie Ferdinande: Rivaroxaban in Cirrhosis and the Path Toward Individualized Anticoagulation
-
Mar 11, 2026, 15:34Sheharyar Raza: When More Testing Isn’t Always Better in Healthy Donor Screening
-
Mar 11, 2026, 15:26Maria Τektonidou: TMN Manifestation Scores and Mortality in Antiphospholipid Syndrome
-
Mar 11, 2026, 15:24Calum Robb: A Simplified Flow Cytometry Method for Measuring Human NETs
-
Mar 11, 2026, 15:19Sharmila Manian: Why Color-Coding is a Lifesaver in Patient Blood Management
-
Mar 11, 2026, 15:10Carlos Andrés Vergara Sánchez: Insights From the POLY-ACS Trial on Post-ACS Medication Adherence
-
Mar 11, 2026, 15:03Abdul Mannan: Why Early Recognition of APML-Associated DIC Saves Lives